Home › Diffuse Scleroderma › California › Los Angeles
Diffuse Scleroderma clinical trials in Los Angeles, CA
6 studies for Diffuse Scleroderma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
RecruitingPhase 2
- UCLA, Los Angeles
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RecruitingPhase 2
- University of California Los Angeles Scleroderma Center, Los Angeles
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
RecruitingPhase 3
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Los Angeles, Los Angeles
Diffuse Scleroderma trials in other cities
- New York City, NY8 studies
- Chicago, IL7 studies
- Ann Arbor, MI7 studies
- Durham, NC6 studies
- Boston, MA5 studies
- Houston, TX5 studies
- Baltimore, MD5 studies
- Kansas City, KS4 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- New Orleans, LA4 studies
- Charleston, SC3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer71 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer49 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.